Table 1 Comparison of Cx26 and Cx23 expression between the primary breast cancers and matching lymph node metastases.
| Expression level | Cx26 expression in metastatic regional lymph nodes | Cx43 expression in metastatic regional lymph nodes | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Negative (n = 6) | Positive (1+) (n = 180 | Positive (2+) (n = 27) | Total (%) (n = 51) | Negative (n = 2) | Positive (1+) (n = 14) | Positive (2+) (n = 35) | Total (%) (n = 51) | |||||||||
| Expression in PT | ||||||||||||||||
| Negative (n = 24) | 5 (9.8%) | 8 (15.7%) | 11 (21.5%) | 24 (47%) | 2 (3.9%) | 2 (3.9%) | 5 (9.8%) | 9 (17.6%) | ||||||||
| Positive (1+) (n = 19) | 1 (2%) | 8 (15.7%) | 10 (19.6%) | 19 (37.3%) | 0 (0%) | 6 (11.8%) | 11 (21.5%) | 17 (33.3%) | ||||||||
| Positive (2+) (n = 8) | 0 (0%) | 2 (3.9%) | 6 (11.8%) | 8 (15.7%) | 0 (0%) | 6 (11.8%) | 19 (37.3%) | 25 (49.1%) | ||||||||
| Total (%) (n = 51) | 6 (11.8%) | 18 (35.3%) | 27 (52.9%) | 51 (100%) | 2 (3.9%) | 14 (27.5%) | 35 (68.6%) | 51 (100%) | ||||||||